Comprehensive Pan-Cancer Analysis Reveals the Potential Biological, Immunological, and Prognostic Value of NKG2A

Figure 8

Correlation of NKG2A expression with immune and molecular subtypes of pan-cancer. (a) Correlation of NKG2A expression with immune subtypes of LUSC, MESO, BLCA, BRCA, CESC, CHOL, COAD, HNSC, KIRC, LUAD, OV, PAAD, READ, SARC, SKCM, TCGT, UCEC, and STAD. (b) Correlation of NKG2A expression with molecular subtypes in BRCA, COAD, ESCA, HNSC, LUSC, OV, READ, and STAD. C1: wound healing, C2: IFN-γ dominant, C3: inflammatory, C4: lymphocyte depleted, C5: immune quiet, and C6: TGF-b dominant.

(a)

(b)